Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort

Endocrine Practice · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles